You and Blade should arm wrestle for the title of least knowledgable biotech investor of BV.
Aside from this being frustratingly uncivil I would suggest it is, from a practical standpoint, incorrect. E.g. in the argument over GERN recently blade was assumed to be completely incorrect on the interpretation of the abstract - but ended up being more correct than many of us gave him credit for. And financially very correct.
Blade, and one or two others, come from a different perspective than the science/math type of bent prevalent on this boards. A more social networking, company body language style of investing - but without the "rah, rah" naivete that is sooo common in biotech (especially in those without the science/math grounding). I personally find them *more* useful than 'just another science perspective' - precisely because their viewpoint is different while still avoiding the rah, rah dangers of biotech.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.